These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25931481)

  • 21. Novel Aerosol Delivery Devices.
    Singh S; Kanbar-Agha F; Sharafkhaneh A
    Semin Respir Crit Care Med; 2015 Aug; 36(4):543-51. PubMed ID: 26238640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative changes in PaO2 in moderately hypoxemic COPD patients treated with almitrine versus placebo for one year].
    Górecka D; Sliwinski P; Palasiewicz G; Pachocki R; Zielinski J;
    Rev Mal Respir; 2001 Sep; 18(4 Pt 2):S15-7. PubMed ID: 11787328
    [No Abstract]   [Full Text] [Related]  

  • 23. Airway disease: the use of large animal models for drug discovery.
    Van der Velden J; Snibson KJ
    Pulm Pharmacol Ther; 2011 Oct; 24(5):525-32. PubMed ID: 21356324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.
    Nakawah MO; Hawkins C; Barbandi F
    J Am Board Fam Med; 2013; 26(4):470-7. PubMed ID: 23833163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New GOLD guidelines for the therapy of COPD].
    Hausen T
    Pneumologie; 2012 Dec; 66(12):768. PubMed ID: 23225409
    [No Abstract]   [Full Text] [Related]  

  • 26. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
    Beeh KM; Beier J
    Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The global burden of chronic respiratory disease in adults.
    Burney P; Jarvis D; Perez-Padilla R
    Int J Tuberc Lung Dis; 2015 Jan; 19(1):10-20. PubMed ID: 25519785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Development for Asthma and COPD: A Regulatory Perspective.
    Mann M; Meyer RJ
    Respir Care; 2018 Jun; 63(6):797-817. PubMed ID: 29794212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transient receptor potential vanilloid 1: role in airway inflammation and disease.
    Geppetti P; Materazzi S; Nicoletti P
    Eur J Pharmacol; 2006 Mar; 533(1-3):207-14. PubMed ID: 16464449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breaking down barriers to lung health.
    Barnes PJ; Ward B; Barry M
    Lancet Respir Med; 2014 Sep; 2(9):687-9. PubMed ID: 25209990
    [No Abstract]   [Full Text] [Related]  

  • 31. [What is the danger of long-term application of beta blockers in patients with ischemic heart disease and concomitant chronic obstructive pulmonary disease?].
    Kozlova LI; Aĭsanov ZR; Chuchalin AG
    Ter Arkh; 2005; 77(3):18-23. PubMed ID: 15881093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential medicines for COPD and asthma in low and middle-income countries.
    Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
    Thorax; 2014 Dec; 69(12):1149-51. PubMed ID: 24590803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunities in respiratory drug delivery.
    Pritchard JN; Giles RD
    Ther Deliv; 2014 Dec; 5(12):1261-73. PubMed ID: 25531928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma.
    Onions ST; Ito K; Charron CE; Brown RJ; Colucci M; Frickel F; Hardy G; Joly K; King-Underwood J; Kizawa Y; Knowles I; Murray PJ; Novak A; Rani A; Rapeport G; Smith A; Strong P; Taddei DM; Williams JG
    J Med Chem; 2016 Mar; 59(5):1727-46. PubMed ID: 26800309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of inhaled anticholinergic drugs (tiotropium bromide) on asthma patients with persistent obstructive ventilatory impairment].
    Nogami H; Honjo S; Iwanaga T
    Arerugi; 2012 Nov; 61(11):1675-82. PubMed ID: 23328224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technology evaluation: EPI-2010, EpiGenesis.
    Zhang Z
    Curr Opin Mol Ther; 2002 Jun; 4(3):275-80. PubMed ID: 12139314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A flexible blueprint for the future of drug development.
    Barker R
    Lancet; 2010 Jan; 375(9712):357-9. PubMed ID: 20113813
    [No Abstract]   [Full Text] [Related]  

  • 38. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [SEPAR-ALAT consensus for inhaled therapies].
    ; ;
    Arch Bronconeumol; 2013 Jun; 49 Suppl 1():2-14. PubMed ID: 23967487
    [No Abstract]   [Full Text] [Related]  

  • 40. The paradox of respiratory R&D, and why 'inhaled-by-design' heralds a new dawn in asthma and chronic obstructive pulmonary disease treatments.
    Yeadon M
    Future Med Chem; 2011 Oct; 3(13):1581-3. PubMed ID: 21942249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.